PAS
PTCT icon

Point72 Asia (Singapore)’s PTC Therapeutics PTCT Stock Holding History

Point72 Asia (Singapore)’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,422
Closed -$123K – 1191
2025
Q1 		$123K Buy
2,422
+716
+42% +$35.7K 0.03% 375
2024
Q4 		$77K Buy
+1,706
New +$73K 0.02% 423
2024
Q3 		– Sell
-10,971
Closed -$335K – 1244
2024
Q2 		$335K Buy
+10,971
New +$355K 0.07% 206

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asia (Singapore)'s PTCT Position: Q2 2025 in Review

Point72 Asia (Singapore) sold out of PTC Therapeutics (PTCT) in Q2 2025, closing a stake of 2,422 shares — an estimated $123K sold.

Point72 Asia (Singapore) first reported a position in PTCT in Q2 2024 and held it in 3 quarters. The position peaked at $335K in Q2 2024. 283 funds tracked by Wall St. Rank hold PTCT as of Q2 2025.

  • Point72 Asia (Singapore) reported no remaining PTC Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 2,422 PTC Therapeutics shares in Q2 2025, an estimated $123K.
  • Point72 Asia (Singapore) first reported a position in PTC Therapeutics in Q2 2024 and held it in 3 quarters.
  • Point72 Asia (Singapore)'s PTC Therapeutics position peaked at $335K in Q2 2024.
  • 283 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2025, filed 14 Aug 2025.